Philip Morris International Inc. Quarterly Report for Q3 Ended Sep 30, 2024

Summary

Philip Morris International Inc. (PM) reported strong financial performance for the nine months ended September 30, 2024. Net revenues increased by 7.8% to $28.2 billion, and diluted EPS grew by 35.5% to $4.89, driven by favorable pricing across combustible tobacco and growth in smoke-free products, particularly ZYN nicotine pouches and IQOS heated tobacco products. The company's strategic shift towards a smoke-free future continues to gain momentum, with smoke-free product revenues up 16.1% year-over-year. Despite currency headwinds and ongoing investments in its smoke-free portfolio, PMI demonstrated robust operational improvements. However, the company did record an impairment charge of $198 million related to the expected sale of its Vectura Group business and a $45 million charge for an Egypt sales tax assessment. Management provided an updated full-year outlook, expecting net cash provided by operating activities of approximately $11 billion, reflecting confidence in continued growth and profitability.

Key Highlights

• 1Net revenues increased by 7.8% to $28.2 billion for the nine months ended September 30, 2024, compared to the prior year.
• 2Diluted EPS rose significantly by 35.5% to $4.89 for the nine months ended September 30, 2024.
• 3Smoke-free product revenues saw a substantial increase of 16.1% for the nine months ended September 30, 2024.
• 4The Americas region showed particularly strong revenue growth of 19.8%, largely driven by ZYN nicotine pouches in the U.S.
• 5The company recorded an impairment charge of $198 million related to the planned sale of its Vectura Group business.
• 6An Egypt sales tax charge of $45 million was recorded, impacting the SSEA, CIS & MEA segment.
• 7PMI anticipates full-year net cash provided by operating activities to be around $11 billion.

Frequently Asked Questions